Anggot, Gregorio .

HRN: 01-24-46  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/08/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
06/08/2025
06/14/2025
IV
300mg
Q12H
E. Coli Pneumonia Infection
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: